Source: International Congress 2018 – Sleep and breathing control: phenotypes
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Ni (Taichung, Taiwan), Y. Lo (Taipei, Taiwan), T. Wang (Taipei, Taiwan), T. Lin (Taipei, Taiwan). Laryngeal obstruction in moderate and severe obstructive sleep apnea patients requested higher CPAP level during treatments. 4367

Member's Comments

No comment yet.

Related content which might interest you: The effect of CPAP treatment on Galectin-3 level in patients with severe obstructive sleep apnea Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 Role of CPAP treatment in elderly with moderate obstructive sleep apnea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 Comparison of auto-adjusting and fixed positive airway pressure therapy in patients with mild to moderate obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2003; 22: Suppl. 45, 95s Year: 2003 Effect of treating severe nasal obstruction on the severity of obstructive sleep apnoea Source: Eur Respir J 2005; 25: 521-527 Year: 2005 Treatment of early undiagnosed airflow obstruction in patients of OSA on CPAP improves sleep quality and symptoms Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes Year: 2021 Efficacy of continuous positive airway pressure in treatment of patients with bradyarrhythmias associated with obstructive sleep apnoea syndrome Source: Annual Congress 2006 - Cardiovascular consequences of obstructive sleep apnoea Year: 2006 CPAP improves chronic cough in patients with obstructive sleep apnoea – a pilot study Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 Hypercapnia and respiratory drive in obstructive sleep apnoea patients before and after CPAP treatment Source: Eur Respir J 2002; 20: Suppl. 38, 103s Year: 2002 Nasal resistance and CPAP compliance in a large series of obstructive sleep apnea (OSA) patients Source: Eur Respir J 2006; 28: Suppl. 50, 408s Year: 2006 A study of insulin resistance in moderate to severe obstructive sleep apnea in non diabetics and its response to nasal CPAP treatment Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011 Adherence to positive airway pressure in non-sleepy patients with obstructive sleep apnoea Source: Eur Respir J 2013; 42: 863-866 Year: 2013 Nasal inflammation and compliance with nasal CPAP therapy in obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Twenty years compliance with continuous positive air pressure treatment in patients with severe obstructive sleep apnea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 Telecoaching to improve physical activity in patients with obstructive sleep apnea treated with CPAP Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence Year: 2020 Evaluation of continuous positive airway pressure compliance in a group of obstructive sleep apnea patients Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012 Index for comfort of patients with obstructive sleep apnea on continuous positive airway pressure therapy Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 Is the daily duration of nasal CPAP ventilation the main determinant of improvement of blood gases in OSAS (obstructive sleep apnoea syndrome) patients? Source: Eur Respir J 2001; 18: Suppl. 33, 390s Year: 2001 An indicator of upper airway obstruction in obstructive sleep apnea patients – a preliminary analysis Source: Eur Respir J 2004; 24: Suppl. 48, 119s Year: 2004 Effect of multiple-dose treatment with daridorexant on nighttime respiratory function in patients with mild and moderate obstructive sleep apnea (OSA) Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects Year: 2020 CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD Source: Eur Respir J 2010; 35: 132-137 Year: 2010